We are live on ! Find out more
KCM

KRS Capital Management Portfolio holdings

AUM $215M
1-Year Est. Return 69.3%
This Fund
S&P 500
This Quarter Est. Return
-7.23%
1 Year Est. Return
+69.3%
3 Year Est. Return
+232.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$92.4M
AUM Growth
-$24.2M
Cap. Flow
-$14.9M
Cap. Flow %
-16.14%
Top 10 Hldgs %
40.1%
Holding
400
New
–
Increased
65
Reduced
21
Closed
286

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$647K
2
HBAN icon
Huntington Bancshares
HBAN
+$175K
3
DHR icon
Danaher
DHR
+$142K
4
U icon
Unity
U
+$108K
5
XYZ
Block Inc
XYZ
+$105K

Top Sells

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$570K
2
TER icon
Teradyne
TER
+$296K
3
XYL icon
Xylem
XYL
+$293K
4
SPOT icon
Spotify
SPOT
+$234K
5
RBLX icon
Roblox
RBLX
+$233K

Sector Composition

Rank Sector Weight
1 Technology 51.09%
2 Healthcare 13.04%
3 Consumer Discretionary 9.43%
4 Financials 7.08%
5 Communication Services 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVX icon
101
Chevron
CVX
$366B
$246K 0.27%
1,514
+5
+0.3% +$717
SOFI icon
102
SoFi Technologies
SOFI
$23.7B
$240K 0.26%
25,500
+6,185
+32% +$71K
VOO icon
103
Vanguard S&P 500 ETF
VOO
$1.01T
$234K 0.25%
564
– –
ADP icon
104
Automatic Data Processing
ADP
$108B
$232K 0.25%
1,020
– –
IVE icon
105
iShares S&P 500 Value ETF
IVE
$49.8B
$232K 0.25%
1,495
– –
LOGI icon
106
Logitech
LOGI
$15.2B
$232K 0.25%
3,145
– –
FDX icon
107
FedEx
FDX
$75.4B
$221K 0.24%
958
– –
REGN icon
108
Regeneron Pharmaceuticals
REGN
$80.8B
$220K 0.24%
315
– –
ENB icon
109
Enbridge
ENB
$112B
$215K 0.23%
4,678
+100
+2% +$4.28K
PNC icon
110
PNC Financial Services
PNC
$101B
$214K 0.23%
1,160
+47
+4% +$9.5K
PARA
111
DELISTED
Paramount Global Class B
PARA
$210K 0.23%
5,571
-1,175
-17% -$40K
NXDR
112
Nextdoor Holdings
NXDR
$986M
$91K 0.1%
15,245
+1,595
+12% +$9.71K
AA icon
113
Alcoa
AA
$13.2B
– –
-83
Closed -$4K
ADBE icon
114
Adobe
ADBE
$105B
– –
-200
Closed -$113K
ADM icon
115
Archer Daniels Midland
ADM
$36.9B
– –
-315
Closed -$21K
ADPT icon
116
Adaptive Biotechnologies
ADPT
$3.97B
– –
-300
Closed -$8K
AEP icon
117
American Electric Power
AEP
$68.4B
– –
-1,502
Closed -$133K
AFRM icon
118
Affirm
AFRM
$25.2B
– –
-805
Closed -$80K
AIVI icon
119
WisdomTree International AI Enhanced Value Fund
AIVI
$63.9M
– –
-200
Closed -$8K
AKAM icon
120
Akamai
AKAM
$16.1B
– –
-900
Closed -$105K
ALC icon
121
Alcon
ALC
$35B
– –
-111
Closed -$9K
ALB icon
122
Albemarle
ALB
$15.5B
– –
-225
Closed -$52K
ALL icon
123
Allstate
ALL
$67.5B
– –
-102
Closed -$12K
ALLY icon
124
Ally Financial
ALLY
$13.3B
– –
-453
Closed -$21K
ALNY icon
125
Alnylam Pharmaceuticals
ALNY
$29.3B
– –
-200
Closed -$33K
3 4
5
6 7

Similar funds

VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
VEA
Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
TSS
Taylor Securities Services Harrisburg, Pennsylvania $214M AUM
CMBA
C.M. Bidwell & Associates Honolulu, Hawaii $214M AUM 18.82% 1-Year Est. Return
IH
IES Holdings Houston, Texas $214M AUM

KRS Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, KRS Capital Management held 400 positions worth $92.4M, down 21% from $117M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

KRS Capital Management withdrew a net $14.9M in Q1 2022, closing 286 positions and reducing 21 holdings. Its most notable exit was Xilinx Inc, an estimated $570K position sold in full.

By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 46% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, KRS Capital Management added an estimated $647K to Advanced Micro Devices.

  • KRS Capital Management added most to Advanced Micro Devices in Q1 2022, an estimated $647K increase.
  • KRS Capital Management's biggest Q1 2022 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $139K.
  • KRS Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $570K.
  • KRS Capital Management's ten largest holdings make up 40% of its $92.4M portfolio in Q1 2022.
  • KRS Capital Management opened 0 new positions and closed 286 in Q1 2022.
  • KRS Capital Management's portfolio value fell 21% quarter-over-quarter to $92.4M.

Based on KRS Capital Management's 13F filing for Q1 2022, filed 27 Apr 2022.